Prevalence of drug-drug interactions in oncology patients enrolled on National Clinical Trials Network oncology clinical trials

Prevalence of drug-drug interactions in oncology patients enrolled on National Clinical Trials Network oncology clinical trials

Abstract Background Drug-drug interactions (DDIs) in subjects enrolling in clinical trials can impact not only safety of the patient but also study drug outcomes and data validity. This makes it critical to adequately screen and manage DDIs. The study objective was to determine the prevalence of DDI...

Full description

Bibliographic Details
Main Authors: Lauren A. Marcath, Taylor D. Coe, Emily K. Hoylman, Bruce G. Redman, Daniel L. Hertz
Format: Article
Language:English
Published: BMC 2018-11-01
Series:BMC Cancer
Subjects:
Oncology clinical trial drug interaction
Online Access:http://link.springer.com/article/10.1186/s12885-018-5076-0

Similar Items

Similar Items